NCT01031524View on ClinicalTrials.gov

Trial to Assess the Efficacy of Malaria Vaccine PfCS 102

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

July 31, 2004

Study Completion Date

November 30, 2004

Conditions
Plasmodium Falciparum Malaria
Interventions
BIOLOGICAL

PfCS102

Antigen of the sporozoite protein

BIOLOGICAL

Montanide ISA 720

adjuvant alone

Trial Locations (1)

1011

Department of Ambulatory Care and Community Medicine; University Hospital, Lausanne

All Listed Sponsors
collaborator

Centre Hospitalier Universitaire Vaudois

OTHER

collaborator

Radboud University Medical Center

OTHER

lead

Swiss Tropical & Public Health Institute

OTHER

NCT01031524 - Trial to Assess the Efficacy of Malaria Vaccine PfCS 102 | Biotech Hunter | Biotech Hunter